BamSEC and AlphaSense Join Forces
Learn More

Phio Pharmaceuticals Corp.

NASDAQ: PHIO    
Share price (1/8/25): $1.69    
Market cap (1/8/25): $1.783 million
Search in Documents
Key Exhibits
External Links

Articles of Incorporation Filter

EX-3.1
from 8-K 1 page Certificate of Amendment to the Amended and Restated Certificate of Incorporation of Phio Pharmaceuticals Corp
12/34/56
EX-3.1
from 8-K 1 page Certificate of Amendment to the Amended and Restated Certificate of Incorporation of Phio Pharmaceuticals Corp
12/34/56
EX-3.1
from 8-K 3 pages Phio Pharmaceuticals Corp. Certificate of Designation of Series D Preferred Stock Pursuant to Section 151 of the General Corporation Law of the State of Delaware
12/34/56
EX-3.1
from 8-K 8 pages Phio Pharmaceuticals Corp. (The “Corporation”) Sixth Amended & Restated Bylaws Section 1—stockholders
12/34/56
EX-3.1
from 8-K 8 pages Phio Pharmaceuticals Corp. (The “Corporation”) Fifth Amended & Restated Bylaws Section 1—stockholders
12/34/56
EX-3.1
from 8-K 1 page Certificate of Amendment to the Amended and Restated Certificate of Incorporation of Phio Pharmaceuticals Corp
12/34/56
EX-3.1
from 10-Q 8 pages Phio Pharmaceuticals Corp. (The “Corporation”) Fifth Amended & Restated Bylaws Section 1—stockholders
12/34/56
EX-3.4
from 8-K 1 page Specimen Stock Certificate
12/34/56
EX-3.3
from 8-K 9 pages Phio Pharmaceuticals Corp. (The “Corporation”) Fourth Amended & Restated Bylaws Section 1—stockholders
12/34/56
EX-3.2
from 8-K 4 pages Amended and Restated Certificate of Incorporation of Phio Pharmaceuticals Corp
12/34/56
EX-3.1
from 8-K 1 page Certificate of Amendment to the Amended and Restated Certificate of Incorporation of Rxi Pharmaceuticals Corporation
12/34/56
EX-3.1
from 8-K 2 pages Certificate of Amendment to the Amended and Restated Certificate of Incorporation of Rxi Pharmaceuticals Corporation
12/34/56
EX-3.2
from 10-Q 2 pages Certificate Eliminating the Series C Convertible Preferred Stock From the Certificate of Incorporation of Rxi Pharmaceuticals Corporation
12/34/56
EX-3.1
from 10-Q 2 pages Certificate Eliminating the Series B Convertible Preferred Stock From the Certificate of Incorporation of Rxi Pharmaceuticals Corporation
12/34/56
EX-3.1
from 8-K 7 pages Rxi Pharmaceuticals Corporation (The “Corporation”) Third Amended & Restated Bylaws Section 1—stockholders
12/34/56
EX-3.1
from 8-K 14 pages Rxi Pharmaceuticals Corporation Certificate of Designation of Preferences, Rights and Limitations of Series C Convertible Preferred Stock Pursuant to Section 151 of the Delaware General Corporation Law
12/34/56
EX-3.1
from 8-K 19 pages Rxi Pharmaceuticals Corporation Certificate of Designation of Preferences, Rights and Limitations of Series B Convertible Preferred Stock Pursuant to Section 151 of the Delaware General Corporation Law
12/34/56
EX-3.11
from S-1/A 19 pages Rxi Pharmaceuticals Corporation Certificate of Designation of Preferences, Rights and Limitations of Series B Convertible Preferred Stock Pursuant to Section 151 of the Delaware General Corporation Law 1
12/34/56
EX-3.11
from S-1/A 19 pages Rxi Pharmaceuticals Corporation Certificate of Designation of Preferences, Rights and Limitations of Series B Convertible Preferred Stock Pursuant to Section 151 of the Delaware General Corporation Law 1
12/34/56
EX-3.1
from 8-K 3 pages Certificate of Amendment to the Amended and Restated Certificate of Incorporation of Rxi Pharmaceuticals Corporation
12/34/56